This HTML5 document contains 79 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n26http://linked.opendata.cz/resource/drugbank/drug/DB00202/identifier/chebi/
n14http://linked.opendata.cz/resource/AHFS/
foafhttp://xmlns.com/foaf/0.1/
n28http://linked.opendata.cz/resource/mesh/concept/
n4http://linked.opendata.cz/resource/drugbank/company/
n6http://linked.opendata.cz/resource/drugbank/dosage/
n20http://linked.opendata.cz/resource/drugbank/drug/DB00202/identifier/wikipedia/
n19http://linked.opendata.cz/resource/drugbank/drug/DB00202/identifier/pharmgkb/
n22http://linked.opendata.cz/resource/drugbank/drug/DB00202/identifier/kegg-compound/
n11http://bio2rdf.org/drugbank:
n23http://linked.opendata.cz/resource/drugbank/drug/DB00202/identifier/pubchem-compound/
admshttp://www.w3.org/ns/adms#
n24http://linked.opendata.cz/resource/drugbank/drug/DB00202/identifier/pubchem-substance/
n16http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n21http://linked.opendata.cz/resource/drugbank/drug/DB00202/identifier/iuphar/
n31http://linked.opendata.cz/resource/drugbank/drug/DB00202/identifier/drugbank/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n25http://linked.opendata.cz/resource/drugbank/medicinal-product/
owlhttp://www.w3.org/2002/07/owl#
n27http://linked.opendata.cz/ontology/mesh/
n29http://linked.opendata.cz/resource/drugbank/drug/DB00202/identifier/guide-to-pharmacology/
n3http://linked.opendata.cz/ontology/drugbank/
n12http://www.drugs.com/cdi/
n9http://www.rxlist.com/cgi/generic2/
n18http://linked.opendata.cz/resource/drugbank/drug/DB00202/identifier/national-drug-code-directory/
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/resource/atc/
n30http://linked.opendata.cz/resource/drugbank/drug/DB00202/identifier/chemspider/
n13http://linked.opendata.cz/ontology/sukl/drug/

Statements

Subject Item
n2:DB00202
rdf:type
n3:Drug
n3:description
A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for. [PubChem]
n3:dosage
n6:271B5A5B-363D-11E5-9242-09173F13E4C5 n6:271B5A5C-363D-11E5-9242-09173F13E4C5
n3:generalReferences
# Jonsson M, Dabrowski M, Gurley DA, Larsson O, Johnson EC, Fredholm BB, Eriksson LI: Activation and inhibition of human muscular and neuronal nicotinic acetylcholine receptors by succinylcholine. Anesthesiology. 2006 Apr;104(4):724-33. "Pubmed":http://www.ncbi.nlm.nih.gov/pubmed/16571968
n3:group
approved
n3:indication
Used in surgical procedures where a rapid onset and brief duration of muscle relaxation is needed (includes intubation, endoscopies, and ECT)
n3:manufacturer
n4:271B5A53-363D-11E5-9242-09173F13E4C5 n4:271B5A56-363D-11E5-9242-09173F13E4C5 n4:271B5A57-363D-11E5-9242-09173F13E4C5 n4:271B5A54-363D-11E5-9242-09173F13E4C5 n4:271B5A55-363D-11E5-9242-09173F13E4C5
owl:sameAs
n11:DB00202 n16:DB00202
dcterms:title
Succinylcholine
adms:identifier
n18:0781-3009-95 n19:PA451522 n20:Succinylcholine n21:4004 n22:C07546 n23:5314 n24:46506023 n26:45652 n29:4004 n30:5123 n31:DB00202
n3:mechanismOfAction
The mechanism of action of Succinylcholine involves what appears to be a "persistent" depolarization of the neuromuscular junction. This depolarization is caused by Succinylcholine mimicking the effect of acetylcholine but without being rapidly hydrolysed by acetylcholinesterase. This depolarization leads to desensitization.
n3:packager
n4:271B5A51-363D-11E5-9242-09173F13E4C5 n4:271B5A4F-363D-11E5-9242-09173F13E4C5 n4:271B5A52-363D-11E5-9242-09173F13E4C5 n4:271B5A50-363D-11E5-9242-09173F13E4C5
n3:routeOfElimination
About 10% of the drug is excreted unchanged in the urine.
n3:synonym
Suxamethonium Succinic acid, diester with choline Succinylcholine 2,2'-[(1,4-DIOXOBUTANE-1,4-diyl)bis(oxy)]bis(N,N,N-trimethylethanaminium) Dicholine succinate Succinoylcholine Succinylbischoline Succinocholine Succinyldicholine
n13:hasAHFSCode
n14:12-20-00
n3:salt
n3:synthesisReference
Walter Raml, Gunther Eichberger, "Process for the preparation of succinylcholine halides." U.S. Patent US5206420, issued April 27, 1993.
n27:hasConcept
n28:M0020712
foaf:page
n9:succinyl.htm n12:succinylcholine.html
n3:IUPAC-Name
n7:271B5A61-363D-11E5-9242-09173F13E4C5
n3:InChI
n7:271B5A67-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n7:271B5A66-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n7:271B5A63-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n7:271B5A64-363D-11E5-9242-09173F13E4C5
n3:SMILES
n7:271B5A65-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n7:271B5A5F-363D-11E5-9242-09173F13E4C5
n3:logP
n7:271B5A5D-363D-11E5-9242-09173F13E4C5 n7:271B5A60-363D-11E5-9242-09173F13E4C5
n3:logS
n7:271B5A5E-363D-11E5-9242-09173F13E4C5
n13:hasATCCode
n15:M03AB01
n3:H-Bond-Acceptor-Count
n7:271B5A6D-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n7:271B5A6E-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n7:271B5A68-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n7:271B5A69-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n7:271B5A6B-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n7:271B5A6A-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n7:271B5A6C-363D-11E5-9242-09173F13E4C5
n3:affectedOrganism
Humans and other mammals
n3:casRegistryNumber
306-40-1
n3:category
n3:containedIn
n25:271B5A5A-363D-11E5-9242-09173F13E4C5 n25:271B5A58-363D-11E5-9242-09173F13E4C5 n25:271B5A59-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n7:271B5A72-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n7:271B5A74-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n7:271B5A75-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n7:271B5A71-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n7:271B5A70-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n7:271B5A73-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n7:271B5A62-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n7:271B5A6F-363D-11E5-9242-09173F13E4C5